دورية أكاديمية
Impact of an Intensive Lifestyle Intervention on Use and Cost of Medical Services Among Overweight and Obese Adults With Type 2 Diabetes: The Action for Health in Diabetes
العنوان: | Impact of an Intensive Lifestyle Intervention on Use and Cost of Medical Services Among Overweight and Obese Adults With Type 2 Diabetes: The Action for Health in Diabetes |
---|---|
المؤلفون: | Espeland, MA, Glick, HA, Bertoni, A, Brancati, FL, Bray, GA, Clark, JM, Curtis, JM, Egan, C, Evans, M, Foreyt, JP, Ghazarian, S, Gregg, EW, Hazuda, HP, Hill, JO, Hire, D, Horton, ES, Hubbard, VS, Jakicic, JM, Jeffery, RW, Johnson, KC, Kahn, SE, Killean, T, Kitabchi, AE, Knowler, WC, Kriska, A, Lewis, CE, Miller, M, Montez, MG, Murillo, A, Nathan, DM, Nyenwe, E, Patricio, J, Peters, AL, Pi-Sunyer, X, Pownall, H, Redmon, B, Rushing, J, Ryan, DH, Safford, M, Tsai, AG, Wadden, TA, Wing, RR, Yanovski, SZ, Zhang, P |
المصدر: | 2556 ; 2548 |
بيانات النشر: | American Diabetes Association |
سنة النشر: | 2014 |
المجموعة: | Imperial College London: Spiral |
مصطلحات موضوعية: | Science & Technology, Life Sciences & Biomedicine, Endocrinology & Metabolism, DISEASE RISK-FACTORS, LOOK-AHEAD ACTION, WEIGHT-LOSS, CARDIOVASCULAR-DISEASE, CLINICAL-TRIAL, MELLITUS, INDIVIDUALS, PREVENTION, METFORMIN, SAVINGS, Adult, Aged, Cardiovascular Diseases, Diabetes Mellitus, Type 2, Female, Follow-Up Studies, Health Care Costs, Health Services, Humans, Life Style, Male, Middle Aged, Obesity, Overweight, Single-Blind Method, Look AHEAD Research Group |
الوصف: | OBJECTIVE To assess the relative impact of an intensive lifestyle intervention (ILI) on use and costs of health care within the Look AHEAD trial. RESEARCH DESIGN AND METHODS A total of 5,121 overweight or obese adults with type 2 diabetes were randomly assigned to an ILI that promoted weight loss or to a comparison condition of diabetes support and education (DSE). Use and costs of health-care services were recorded across an average of 10 years. RESULTS ILI led to reductions in annual hospitalizations (11%, P = 0.004), hospital days (15%, P = 0.01), and number of medications (6%, P < 0.001), resulting in cost savings for hospitalization (10%, P = 0.04) and medication (7%, P < 0.001). ILI produced a mean relative per-person 10-year cost savings of $5,280 (95% CI 3,385–7,175); however, these were not evident among individuals with a history of cardiovascular disease. CONCLUSIONS Compared with DSE over 10 years, ILI participants had fewer hospitalizations, fewer medications, and lower health-care costs. |
نوع الوثيقة: | article in journal/newspaper |
اللغة: | English |
تدمد: | 0149-5992 |
العلاقة: | Diabetes Care; http://hdl.handle.net/10044/1/72373Test; https://doi.org/10.2337/dc14-0093Test |
DOI: | 10.2337/dc14-0093 |
الإتاحة: | https://doi.org/10.2337/dc14-0093Test http://hdl.handle.net/10044/1/72373Test |
حقوق: | © 2014 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. |
رقم الانضمام: | edsbas.D5B72BC9 |
قاعدة البيانات: | BASE |
تدمد: | 01495992 |
---|---|
DOI: | 10.2337/dc14-0093 |